We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
Cap. Flow
+$112M
Cap. Flow %
14.34%
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.02M
2
AVGO icon
Broadcom
AVGO
+$6.42M
3
TSM icon
TSMC
TSM
+$6.34M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$6.09M
5
OTEX icon
Open Text
OTEX
+$5.5M

Top Sells

Rank Stock Value
1
FOXA icon
Fox Class A
FOXA
+$9.87M
2
FANG icon
Diamondback Energy
FANG
+$9.52M
3
HD icon
Home Depot
HD
+$7.05M
4
MET icon
MetLife
MET
+$6.8M
5
ACN icon
Accenture
ACN
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 21.53%
2 Consumer Discretionary 17.87%
3 Industrials 15.32%
4 Healthcare 12.76%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVA icon
301
Privia Health
PRVA
$3.21B
$449K 0.06%
17,214
-30,827
-64% -$814K
DV icon
302
DoubleVerify
DV
$1.62B
$445K 0.06%
+11,443
New +$369K
PG icon
303
Procter & Gamble
PG
$343B
$444K 0.06%
+2,929
New +$441K
HI
304
DELISTED
Hillenbrand
HI
$444K 0.06%
+8,653
New +$416K
ON icon
305
ON Semiconductor
ON
$33.8B
$438K 0.06%
4,632
+1,754
+61% +$145K
WMT icon
306
Walmart Inc
WMT
$871B
$438K 0.06%
+8,352
New +$421K
BCS icon
307
Barclays
BCS
$94.1B
$437K 0.06%
55,560
+12,176
+28% +$94.2K
TWST icon
308
Twist Bioscience
TWST
$5.62B
$432K 0.06%
+21,123
New +$316K
CAT icon
309
Caterpillar
CAT
$409B
$432K 0.06%
+1,756
New +$392K
KNSA icon
310
Kiniksa Pharmaceuticals
KNSA
$4.83B
$430K 0.06%
30,552
-1,322
-4% -$17.7K
ISRG icon
311
Intuitive Surgical
ISRG
$121B
$427K 0.05%
+1,249
New +$378K
KLAC icon
312
KLA
KLAC
$275B
$426K 0.05%
+8,790
New +$367K
AMAT icon
313
Applied Materials
AMAT
$426B
$425K 0.05%
+2,942
New +$368K
BLDR icon
314
Builders FirstSource
BLDR
$7.84B
$424K 0.05%
3,120
-1,585
-34% -$176K
GE icon
315
GE Aerospace
GE
$367B
$424K 0.05%
+4,838
New +$392K
SPGI icon
316
S&P Global
SPGI
$126B
$423K 0.05%
+1,056
New +$386K
DCGO icon
317
DocGo
DCGO
$58.9M
$423K 0.05%
45,140
-22,883
-34% -$201K
BA icon
318
Boeing
BA
$165B
$422K 0.05%
+2,000
New +$415K
VECO icon
319
Veeco
VECO
$3.15B
$420K 0.05%
+16,340
New +$359K
NFLX icon
320
Netflix
NFLX
$292B
$416K 0.05%
+9,450
New +$348K
SYK icon
321
Stryker
SYK
$127B
$415K 0.05%
+1,361
New +$393K
SOUN icon
322
SoundHound AI
SOUN
$2.68B
$413K 0.05%
+90,726
New +$270K
AXON
323
Axon Enterprise
AXON
$40.5B
$411K 0.05%
2,106
+203
+11% +$42.1K
TMO icon
324
Thermo Fisher Scientific
TMO
$211B
$410K 0.05%
786
-1,291
-62% -$697K
FWRG icon
325
First Watch Restaurant Group
FWRG
$747M
$405K 0.05%
23,981
-7,847
-25% -$130K

Similar funds

Advisory Research's Q2 2023 Portfolio in Review

As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.

  • Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
  • Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
  • Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
  • Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
  • Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
  • Advisory Research opened 169 new positions and closed 81 in Q2 2023.
  • Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.